IBDEI2O8 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44828,0)
 ;;=M10.9^^200^2234^40
 ;;^UTILITY(U,$J,358.3,44828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44828,1,3,0)
 ;;=3^Gout,Unspec
 ;;^UTILITY(U,$J,358.3,44828,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,44828,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,44829,0)
 ;;=G90.59^^200^2234^34
 ;;^UTILITY(U,$J,358.3,44829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44829,1,3,0)
 ;;=3^Complex Regional Pain Syndrome I,Unspec
 ;;^UTILITY(U,$J,358.3,44829,1,4,0)
 ;;=4^G90.59
 ;;^UTILITY(U,$J,358.3,44829,2)
 ;;=^5004171
 ;;^UTILITY(U,$J,358.3,44830,0)
 ;;=G56.01^^200^2234^12
 ;;^UTILITY(U,$J,358.3,44830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44830,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,44830,1,4,0)
 ;;=4^G56.01
 ;;^UTILITY(U,$J,358.3,44830,2)
 ;;=^5004018
 ;;^UTILITY(U,$J,358.3,44831,0)
 ;;=G56.02^^200^2234^11
 ;;^UTILITY(U,$J,358.3,44831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44831,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,44831,1,4,0)
 ;;=4^G56.02
 ;;^UTILITY(U,$J,358.3,44831,2)
 ;;=^5004019
 ;;^UTILITY(U,$J,358.3,44832,0)
 ;;=G56.21^^200^2234^56
 ;;^UTILITY(U,$J,358.3,44832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44832,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,44832,1,4,0)
 ;;=4^G56.21
 ;;^UTILITY(U,$J,358.3,44832,2)
 ;;=^5004024
 ;;^UTILITY(U,$J,358.3,44833,0)
 ;;=G56.22^^200^2234^55
 ;;^UTILITY(U,$J,358.3,44833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44833,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,44833,1,4,0)
 ;;=4^G56.22
 ;;^UTILITY(U,$J,358.3,44833,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,44834,0)
 ;;=M26.60^^200^2234^163
 ;;^UTILITY(U,$J,358.3,44834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44834,1,3,0)
 ;;=3^Temporomandibular Joint Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,44834,1,4,0)
 ;;=4^M26.60
 ;;^UTILITY(U,$J,358.3,44834,2)
 ;;=^5011714
 ;;^UTILITY(U,$J,358.3,44835,0)
 ;;=L40.52^^200^2234^120
 ;;^UTILITY(U,$J,358.3,44835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44835,1,3,0)
 ;;=3^Psoriatic Arthritis Mutilans
 ;;^UTILITY(U,$J,358.3,44835,1,4,0)
 ;;=4^L40.52
 ;;^UTILITY(U,$J,358.3,44835,2)
 ;;=^5009167
 ;;^UTILITY(U,$J,358.3,44836,0)
 ;;=L40.53^^200^2234^121
 ;;^UTILITY(U,$J,358.3,44836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44836,1,3,0)
 ;;=3^Psoriatic Spondylitis
 ;;^UTILITY(U,$J,358.3,44836,1,4,0)
 ;;=4^L40.53
 ;;^UTILITY(U,$J,358.3,44836,2)
 ;;=^5009168
 ;;^UTILITY(U,$J,358.3,44837,0)
 ;;=M32.9^^200^2234^162
 ;;^UTILITY(U,$J,358.3,44837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44837,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,44837,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,44837,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,44838,0)
 ;;=M32.0^^200^2234^158
 ;;^UTILITY(U,$J,358.3,44838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44838,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Drug-Induced
 ;;^UTILITY(U,$J,358.3,44838,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,44838,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,44839,0)
 ;;=M32.13^^200^2234^160
 ;;^UTILITY(U,$J,358.3,44839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44839,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Lung Involvement
 ;;^UTILITY(U,$J,358.3,44839,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,44839,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,44840,0)
 ;;=M32.14^^200^2234^159
 ;;^UTILITY(U,$J,358.3,44840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44840,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Glomerular Disease
 ;;^UTILITY(U,$J,358.3,44840,1,4,0)
 ;;=4^M32.14
